MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1007/s00423-023-03028-7

Медицинская библиотека · Langenbeck's archives of surgery · 2023

Efficacy of palliative surgery for gastric cancer patients with peritoneal metastasis who still have residual peritoneal dissemination after chemotherapy.

Shinkai Masayuki, Imano Motohiro, Kohda Masashi, Nakanishi Tomoya, Hiraki Yoko, Hagi Takaomi, Kato Hiroaki, Shiraishi Osamu, Yasuda Atsushi, Tsubaki Masanobu, Nishida Shozo, Yasuda Takushi

СтатьяПеревод пока не подготовлен

Аннотация

PURPOSE: Gastric cancer patients with peritoneal metastasis (PM) are generally treated with systemic chemotherapy. When PM has disappeared because of chemotherapy, radical gastrectomy (so-called conversion surgery) is usually performed. We have previously reported the efficacy of conversion surgery, but there are no reports examining the efficacy of palliative gastrectomy for patients with residual PM after chemotherapy. The purpose of this study was to investigate the efficacy of palliative surgery for gastric cancer patients with PM who still have residual peritoneal dissemination after chemotherapy.

METHODS

Twenty-five gastric cancer patients with PM confirmed by laparoscopy and who had received chemotherapy but who still had residual PM were included in this study. Among the 25 patients, palliative surgery was performed in 20 patients (PS group) and chemotherapy was continued in 5 patients (CTx group), and their therapeutic outcomes were compared.

RESULTS

In the PS group, total and distal gastrectomies were performed. Clavien-Dindo grade I postoperative complications occurred in two patients (10%). There were no treatment-related deaths. Postoperative chemotherapy was performed all cases. In the PS group, the median survival time (MST) reached 22.5 months, with 1- and 2-year overall survival (OS) rates of 95% and 45%, respectively, whereas in the CTx group, the MST was 15.8 months, and the 1- and 2-year OS rates were 60% and 0%, respectively. The PS group had significantly longer OS than the CTx group (P=0.044).

CONCLUSIONS

Palliative surgery is safe and may prolong survival in gastric cancer patients with residual PM after chemotherapy.

Для цитирования: Shinkai Masayuki, Imano Motohiro, Kohda Masashi, Nakanishi Tomoya, Hiraki Yoko, Hagi Takaomi, Kato Hiroaki, Shiraishi Osamu, Yasuda Atsushi, Tsubaki Masanobu, Nishida Shozo, Yasuda Takushi. Efficacy of palliative surgery for gastric cancer patients with peritoneal metastasis who still have residual peritoneal dissemination after chemotherapy.. Langenbeck's archives of surgery. 2023. DOI: 10.1007/s00423-023-03028-7.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.